Protocol for a randomized multicenter study for isolated skin vasculitis (ARAMIS) comparing the efficacy of three drugs: azathioprine, colchicine, and dapsone
DiscussionARAMIS will help identify effective agents for skin-limited forms of vasculitis, an understudied group of diseases. The SMARTER design may serve as an example for future trials in rare diseases.Trial registrationClinicalTrials.gov:NCT02939573. Registered on 18 October 2016. (Source: Trials)
Source: Trials - April 27, 2020 Category: Research Source Type: clinical trials
Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris
Condition: Acne Vulgaris Interventions: Drug: Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd); Drug: ACZONE® (dapsone) gel, 7.5% (Allergan, INC.); Other: Placebo for Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd) Sponsors: Torrent Pharmaceuticals Limited; Catawba Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2019 Category: Research Source Type: clinical trials
Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris
Condition: Acne Vulgaris Interventions: Drug: Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd); Drug: ACZONE® (dapsone) gel, 7.5% (Allergan, INC.); Other: Placebo for Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd) Sponsors: Torrent Pharmaceuticals Limited; Catawba Research Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2019 Category: Research Source Type: clinical trials
